Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,913 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Microarray expression profiling in melanoma reveals a BRAF mutation signature.
Pavey S, Johansson P, Packer L, Taylor J, Stark M, Pollock PM, Walker GJ, Boyle GM, Harper U, Cozzi SJ, Hansen K, Yudt L, Schmidt C, Hersey P, Ellem KA, O'Rourke MG, Parsons PG, Meltzer P, Ringnér M, Hayward NK. Pavey S, et al. Among authors: schmidt c. Oncogene. 2004 May 20;23(23):4060-7. doi: 10.1038/sj.onc.1207563. Oncogene. 2004. PMID: 15048078
Characterization of the Melanoma miRNAome by Deep Sequencing.
Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA, Hayward NK. Stark MS, et al. Among authors: schmidt c. PLoS One. 2010 Mar 12;5(3):e9685. doi: 10.1371/journal.pone.0009685. PLoS One. 2010. PMID: 20300190 Free PMC article.
Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene.
Dutton-Regester K, Aoude LG, Nancarrow DJ, Stark MS, O'Connor L, Lanagan C, Pupo GM, Tembe V, Carter CD, O'Rourke M, Scolyer RA, Mann GJ, Schmidt CW, Herington A, Hayward NK. Dutton-Regester K, et al. Among authors: schmidt cw. Genes Chromosomes Cancer. 2012 May;51(5):452-61. doi: 10.1002/gcc.21932. Epub 2012 Jan 17. Genes Chromosomes Cancer. 2012. PMID: 22250051
Immunotherapy, including gene therapy, for metastatic melanoma.
O'Rourke MG, Schmidt CW, O'Rourke TR, Ellem KA. O'Rourke MG, et al. Among authors: schmidt cw. Aust N Z J Surg. 1997 Dec;67(12):834-41. doi: 10.1111/j.1445-2197.1997.tb07607.x. Aust N Z J Surg. 1997. PMID: 9451336 Review.
A high-throughput panel for identifying clinically relevant mutation profiles in melanoma.
Dutton-Regester K, Irwin D, Hunt P, Aoude LG, Tembe V, Pupo GM, Lanagan C, Carter CD, O'Connor L, O'Rourke M, Scolyer RA, Mann GJ, Schmidt CW, Herington A, Hayward NK. Dutton-Regester K, et al. Among authors: schmidt cw. Mol Cancer Ther. 2012 Apr;11(4):888-97. doi: 10.1158/1535-7163.MCT-11-0676. Epub 2012 Mar 1. Mol Cancer Ther. 2012. PMID: 22383533
Dendritic cell immunotherapy for stage IV melanoma.
O'Rourke MG, Johnson MK, Lanagan CM, See JL, O'Connor LE, Slater GJ, Thomas D, Lopez JA, Martinez NR, Ellem KA, Schmidt CW. O'Rourke MG, et al. Melanoma Res. 2007 Oct;17(5):316-22. doi: 10.1097/CMR.0b013e3282c3a73b. Melanoma Res. 2007. PMID: 17885587 Clinical Trial.
5,913 results